|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 7/04 | |
| A61K 38/48 |
| (11) | Number of the document | 2915564 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14197779.3 |
| Date of filing the European patent application | 2008-09-26 | |
| (97) | Date of publication of the European application | 2015-09-09 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-04 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 976343 P | 2007-09-28 | US | |
| 90574 P | 2008-08-20 | US |
| (72) |
LU, Genmin, US
PHILLIPS, David R., US
ANDRE, Patrick, US
SINHA, Uma, US
|
| (73) |
Alexion Pharmaceuticals, Inc.,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (54) | Antidotes for factor XA inhibitors and methods of using the same |
| Antidotes for factor XA inhibitors and methods of using the same |